Syros Pharmaceuticals, Inc. Collaboration Agreements
3 Contracts & Agreements
- Master Collaboration Agreement dated March 7, 2022 between Syros Pharmaceuticals, Inc. and QIAGEN Manchester Limited (Filed With SEC on May 16, 2022)
- License and Collaboration Agreement dated December 17, 2019 by and between the Registrant and Global Blood Therapeutics, Inc (Filed With SEC on March 5, 2020)
- Target Discovery, Research Collaboration and Option Agreement dated January 8, 2018 by and between the Registrant and Incyte Corporation (Filed With SEC on March 12, 2018)
